The overall reduction in PaCO 2 with LTNIV was highly significant (95% CI: −1.03 to −0.69) The high degree of heterogeneity across the studies was observed (I 2 = 76%) A subgroup analyses of studies with a predefined goal for reducing PaCO 2 was conducted.
1
—
—